Public data from the U.S. Securities and Exchange Commission (SEC) EDGAR system shows that Stefano Pessina and his holding company continue to report changes in their WBA stake, which influences Days' corporate strategy. The most recent Form 4 filings indicate no reduction in Stefano's beneficial ownership that would signal a departure from the Days-related business. WBA's 10-K filing for the latest fiscal year confirms that Days remains a core operating segment, with Stefano Pessina listed as executive chairman overseeing the integration of European and U.S. pharmacy assets. The company's market capitalization and ranking among global healthcare retailers remain tied to the performance of the Days chain, as reported in WBA's quarterly earnings release SEC EDGAR company filings for Walgreens Boots Alliance.
Stefano Pessina Role and Days Operations
Stefano Pessina holds the title of executive chairman at WBA and controls a voting stake that gives him decisive influence over Days' store closures, remodels, and private-label product decisions. Under his leadership, Days has continued to expand its front-store health services, including immunizations, chronic care, and prescription synchronization programs. The latest WBA earnings call transcript shows Stefano Pessina highlighting Days' same-store sales growth and digital prescription volume as key performance indicators. Industry rankings from Kantar and IQVIA place Days among the top U.S. pharmacy chains by prescription market share, with Stefano Pessina frequently cited as the strategic driver behind the chain's integration with the broader WBA network. Additional details are available in the Walgreens Boots Alliance earnings presentation Walgreens Boots Alliance 2024 Annual Report.
Days operates thousands of retail locations across the United States, and Stefano Pessina's strategic directives have shaped the chain's approach to store rationalization and technology investment. The most recent corporate strategy update confirms that Stefano continues to oversee the alignment of Days' pharmacy operations with WBA's global procurement and logistics platforms. Data from the National Association of Boards of Pharmacy shows that Days maintains a high rate of state pharmacy license compliance across the locations where Stefano's strategy is applied. WBA's ranking in the Fortune 500 and the Forbes Global 2000 reflects the scale of Days' contribution, with Stefano Pessina listed as a key executive in both indexes. For further context, see the Forbes profile of Walgreens Boots Alliance Forbes Wal